Source:http://linkedlifedata.com/resource/pubmed/id/18035048
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2007-12-17
|
pubmed:abstractText |
Akt1 was revealed to interact with Ki-Ras in the cytoplasm of Ki-Ras-transformed human prostate epithelial cells, 267B1/K-ras. Moreover, p65/RelA in the nucleus was found to interact with both Ki-Ras and Akt1, suggesting the nuclear translocation of Akt1:Ki-Ras complex for NF- kappaB activation. In support of this, compared with wild type Akt1, the dominant negative Akt1 mutant was decreased in its nuclear expression, reducing the Ki-Ras-induced NF-kappaB transcriptional activation. Moreover, inhibitors of Ras (sulindac sulfide and farnesyltransferase inhibitor I) or PI3K/Akt (wortmannin), reduced the amounts of Akt1 and Ki-Ras in the nucleus as well as partial NF-kappaB activity. The complete inhibition of Ki-Ras-induced NF-kappaB activation, however, could only be obtained by combined treatment with wortmannin and proteasome inhibitor-1. Accordingly, clonogenic assay showed Akt1 contribution to IkappaBalpha-mediated NF-kappaB activation for oncogenic cell growth by Ki-Ras. Our data suggest a crucial role of Ki-Ras:Akt1 complex in NF-kappaB transcriptional activation and enhancement of cell survival.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/AKT1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Multiprotein Complexes,
http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-akt,
http://linkedlifedata.com/resource/pubmed/chemical/RELA protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factor RelA
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1090-2104
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
25
|
pubmed:volume |
365
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
771-6
|
pubmed:dateRevised |
2009-12-10
|
pubmed:meshHeading |
pubmed-meshheading:18035048-Cell Line,
pubmed-meshheading:18035048-Cell Nucleus,
pubmed-meshheading:18035048-Epithelial Cells,
pubmed-meshheading:18035048-Humans,
pubmed-meshheading:18035048-Male,
pubmed-meshheading:18035048-Multiprotein Complexes,
pubmed-meshheading:18035048-NF-kappa B,
pubmed-meshheading:18035048-Prostate,
pubmed-meshheading:18035048-Proto-Oncogene Proteins c-akt,
pubmed-meshheading:18035048-Signal Transduction,
pubmed-meshheading:18035048-Transcription Factor RelA,
pubmed-meshheading:18035048-Transcriptional Activation
|
pubmed:year |
2008
|
pubmed:articleTitle |
Complex formation of p65/RelA with nuclear Akt1 for enhanced transcriptional activation of NF-kappaB.
|
pubmed:affiliation |
Functional Metabolomics Research Center, KRIBB, Yuseong, Daejeon, Republic of Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|